According to the latest report by IMARC Group, titled “Autoimmune Disease Diagnosis Market Share: Global Industry Trends, Size, Growth, Opportunity and Forecast 2021-2026,” the global autoimmune disease diagnosis market reached a value of US$ 4.4 Billion in 2020 and expected to grow at a CAGR of 8.10% during 2021-2026.
An autoimmune disease refers to a medical condition that results from an abnormal immune response to a normally functioning body part. The immune system is unable to distinguish between healthy tissues and potentially harmful antigens in this condition. As a result, it releases proteins called autoantibodies to attack the healthy cells that destroy the functioning cells, tissues, and organs of the body. At present, more than 80 types of autoimmune disorders have been identified by scientists that include type I diabetes, psoriasis, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. The diagnosis of these diseases requires a combination of physical examination, antinuclear antibody test (ANA), C-reactive protein (CRP), tissue biopsy and X-rays in order to determine the nature and severity of the condition.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Autoimmune Disease Diagnosis Market Trends:
The global market is primarily driven by the growing prevalence of numerous autoimmune disorders, along with the increasing demand for precise and efficient diagnostic solutions. This has led to the adoption of advanced technologies to conduct multiple tests simultaneously with faster and accurate results. These technologies are also focused on providing an improved diagnosis with higher sensitivity, which is providing an impetus to the market growth. In addition to this, there has been a rising preference for laboratory automation. This, along with the increasing healthcare expenditure, is acting as a major growth-inducing factor. Moreover, numerous government and non-government organizations (NGOs) are undertaking initiatives to spread awareness regarding the diagnosis and treatment of autoimmune disorders. Several research and diagnostics institutes are also investing in programs that aim to develop improved diagnostic methods and novel therapeutic solutions for these medical disorders, which, in turn, is expected to create a positive outlook for the market
Request Free Sample Report: https://www.imarcgroup.com/autoimmune-disease-diagnosis-market/requestsample
Global Autoimmune Disease Diagnosis Market 2021-2026 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Abbott Laboratories, Aesku.Diagnostics GmbH & Co. KG, Beckman Coulter Inc. (Danaher Corporation), bioMérieux SA (Institut Mérieux), Bio-Rad Laboratories Inc., Euroimmun AG (PerkinElmer Inc.), Hemagen Diagnostics Inc., Inova Diagnostics Inc. (Werfen Group S.A.), Myriad Genetics Inc., Quest Diagnostics Incorporated, Siemens Healthineers AG (Siemens AG), SQI Diagnostics, Thermo Fisher Scientific Inc., Trinity Biotech, etc.
The report has segmented the market on the basis of product, disease, test, user and Region
Breakup by Product Type:
Consumables and Assay Kits
Breakup by Disease Type:
Systemic Autoimmune Disease
Localized Autoimmune Disease
Breakup by Test Type:
Routine Laboratory Tests
Autoantibodies and Immunologic Tests
Breakup by End-User:
Breakup by Region:
Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://bit.ly/3HLZCz8
We are updating our reports,If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you in PDF format via email within 24 to 48 hours after the payment confirmation.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Company Name: IMARC Group
Email: [email protected]
Toll Free Number: USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 30 N Gould St, Ste R
Sheridan, WY 82801, USA
Follow us on twitter: @imarcglobal